Registry collecting data from heart failure patients with pulmonary artery pressure sensors
Collects health and heart pressure data from heart failure patients fitted with a pressure sensor.
Plain-language title generated from the registry record
Registry title: HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Key facts
- Where
- Austin, Bloomington, Columbia, Houston, Kansas City, La Jolla, Maplewood, Minneapolis, Portland, Raleigh, and Sioux Falls, United StatesSee the 12 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT06425848, who can take part
Where in United States
- Austin HeartAustin, United StatesTaking people
- Indiana UniversityBloomington, United StatesTaking people
- Prisma HealthColumbia, United StatesTaking people
- Houston Methodist DeBakey Heart and Vascular CenterHouston, United StatesTaking people
- Saint Luke's Health SystemKansas City, United StatesTaking people
- University of Kansas Medical CenterKansas City, United StatesTaking people
- Scripps HealthLa Jolla, United StatesTaking people
- Fairview HealthMaplewood, United StatesNot yet recruiting
- Minneapolis Heart Institute Foundation/ Allina HealthMinneapolis, United StatesTaking people
- Providence Heart InstitutePortland, United StatesTaking people
- University of North Carolina/ Rex Hospital, Inc.Raleigh, United StatesTaking people
- Sanford HealthSioux Falls, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Kansas Medical Center
- Trial code
- NCT06425848
- Record updated
- 22 May 2024
- Original description
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.Read full original descriptionShow less
Hemodynamic Frontiers in Heart Failure Registry
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.
Inclusion: All patients would have been or will be implanted per indications from FDA approval/CHAMPION trial. These would be patients with NYHA (New York Heart Association) Class III heart failure who had a prior hospitalization; Patients who meet the expanded FDA indication (BNP elevation without hospitalization or NYHA class II).
Exclusion: Pregnant women at the scheduled time of PA pressure sensor implant; Patients unable or unwilling to have continuity of care in the heart failure clinic; Patients less than 18 years of age.